These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26773134)

  • 1. Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease.
    Gautier M; Normand AC; L'Ollivier C; Cassagne C; Reynaud-Gaubert M; Dubus JC; Brégeon F; Hendrickx M; Gomez C; Ranque S; Piarroux R
    Med Mycol; 2016 Jul; 54(5):459-70. PubMed ID: 26773134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns.
    Castro C; Galán-Sanchez F; Linares MJ; Tejero R; Ruiz M; Serrano ML; Rodríguez-Iglesias M; Martín-Mazuelos E;
    Med Mycol; 2019 Jun; 57(4):412-420. PubMed ID: 30289467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.
    Iatta R; Nuccio F; Immediato D; Mosca A; De Carlo C; Miragliotta G; Parisi A; Crescenzo G; Otranto D; Cafarchia C
    J Clin Microbiol; 2016 Sep; 54(9):2365-72. PubMed ID: 27413191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: A five-year single-center study in Japan.
    Toyotome T; Saito S; Koshizaki Y; Komatsu R; Matsuzawa T; Yaguchi T
    J Infect Chemother; 2020 Feb; 26(2):321-323. PubMed ID: 31564504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
    Halvaeezadeh M; Jalaee GA; Fatahinia M; Mahmoudabadi AZ
    Microb Pathog; 2023 Aug; 181():106180. PubMed ID: 37257666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.
    Kamali Sarwestani Z; Hashemi SJ; Rezaie S; Gerami Shoar M; Mahmoudi S; Elahi M; Bahardoost M; Tajdini A; Abutalebian S; Daie Ghazvini R
    J Mycol Med; 2018 Jun; 28(2):279-284. PubMed ID: 29540288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species.
    Misra R; Malik A; Singhal S
    Indian J Pathol Microbiol; 2011; 54(1):112-6. PubMed ID: 21393890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibility of molecularly confirmed Aspergillus species from clinical samples.
    Tzar MN; Mustakim S; Yusoff H; Tap RM
    Malays J Pathol; 2024 Apr; 46(1):71-78. PubMed ID: 38682846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifungal susceptibilities of Aspergillus spp. strains isolated from invasive aspergillosis cases].
    Gürcan S; Tikveşli M; Eryildiz C; Evci C; Ener B
    Mikrobiyol Bul; 2010 Apr; 44(2):273-8. PubMed ID: 20549962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification by Molecular Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Profiles of Clinically Significant Rare Aspergillus Species in a Referral Chest Hospital in Delhi, India.
    Masih A; Singh PK; Kathuria S; Agarwal K; Meis JF; Chowdhary A
    J Clin Microbiol; 2016 Sep; 54(9):2354-64. PubMed ID: 27413188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection.
    Hendrickx M; Beguin H; Detandt M
    Mycoses; 2012 Mar; 55(2):148-55. PubMed ID: 21929560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
    Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
    J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Aspergillus tubingensis in a primary skin infection.
    Frías-De-León MG; Rosas-de Paz E; Arenas R; Atoche C; Duarte-Escalante E; Molina de Soschin D; Acosta-Altamirano G; Reyes-Montes MR
    J Mycol Med; 2018 Jun; 28(2):274-278. PubMed ID: 29551443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
    Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
    Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previously unknown species of Aspergillus.
    Gautier M; Normand AC; Ranque S
    Clin Microbiol Infect; 2016 Aug; 22(8):662-9. PubMed ID: 27263029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD; Kiraz N
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity of Aspergillus species isolated from onychomycosis and Aspergillus hongkongensis sp. nov., with implications to antifungal susceptibility testing.
    Tsang CC; Hui TW; Lee KC; Chen JH; Ngan AH; Tam EW; Chan JF; Wu AL; Cheung M; Tse BP; Wu AK; Lai CK; Tsang DN; Que TL; Lam CW; Yuen KY; Lau SK; Woo PC
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):125-34. PubMed ID: 26658315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspergillus tubingensis and Aspergillus niger as the dominant black Aspergillus, use of simple PCR-RFLP for preliminary differentiation.
    Mirhendi H; Zarei F; Motamedi M; Nouripour-Sisakht S
    J Mycol Med; 2016 Mar; 26(1):9-16. PubMed ID: 26852194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.